Ann: IMU RECEIVES ETHICS APPROVAL TO START HER-VAXX NextHERIZON, page-79

And not too long to go, those large numbers will be largely reduced by the attacks of biosims when their patent protections run out.

Enter Hervaxx and PD1vaxx to help protect those numbers In fact, I dare say a Hervaxx/PD1vaxx combo could well blow away the whole Herceptin and Keytruda market simply because the B cell tech will win out in terms of toxicity, tolerability and cost of productions. And that is all assuming that Checkvacc and Vaxinia won't already blow away the B cell tech by then

IMU. A company with so many potentials and possibilities!